CROI 2024 Program Guide

Themed Discussions

524 1:35 PM NIS

Potent HIV Latency Reversal by Lipid Nanoparticles Encapsulating HIV Tat mRNA

Bridget M. Fisher , Paula M Cevaal, Stanislav Kan, Abdalla Ali, Abigail Tan, Rory Shepherd, Youry Kim, Marvin Holz, Damian Purcell, Frank Caruso, Sharon R Lewin, Michael Roche CD4-Targeted mRNA Delivery of Tat Reverses HIV-1 Latency Edward Kreider , Vincent H Wu, Jayme M Nordin, Francesco Pennino, Amie Albertus, Tyler Papp, Obinna Uzosike, Khumoekae Richard, Carol Cheney, Karam Mounzer, Hamideh Parhiz, Michael R Betts, Daniel T Claiborne, Drew Weissman, Luis J Montaner Nanoparticle Delivery of Tat Synergizes With Latency Reversal Agents to Express HIV Antigen Shane D. Falcinelli , Samuel L Raines, Jackson Peterson, Ellen Van Gulck, Jennifer Kirchherr, Isabel Najera, Jerel Vega, Daniel Boden, Nancie M Archin, David M Margolis Ruxolitinib-Mediated HIV-1 Reservoir Decay in A5336 Phase IIa Trial Monica D. Reece , Vincent Marconi, Zhan Zhang, Susan P Ribeiro, Rafick P Sekaly, Deanna A Kulpa, Christina Gavegnano Short-Term BCL-2 Inhibition at ART Initiation Transiently Reduces SIV Reservoir in Rhesus Macaques Tomas Raul Wiche Salinas , Justin L Harper, Kevin Nguyen, James Auger, Laurence Raymond Marchand, Mackenzie Cottrell, Jason Brenchley, Jeffrey Lifson, Brandon Keele, Andrew Badley, Guido Silvestri, Deanna A Kulpa, Mirko Paiardini

523 1:40 PM

525 1:45 PM NIS

521 1:50 PM

522 1:55 PM

Discussion with Audience Questions and Answers

Themed Discussion-11 | Dolutegravir Resistance in Resource-Limited Settings 1:30 PM - 2:30 PM • Mile High Ballroom 1-2-3

Gert U. van Zyl , Stellenbosch University, Cape Town, South Africa Themed Discussion Leader Session Overview

Wednesday

676 1:35 PM

Viremia and Drug Resistance 2 Years After Routine Switching to Dolutegravir-Based First-Line ART Veronika Whitesell Skrivankova, Jacqueline Huwa, Guy Muula, Geldert D Chiwaya, Esau Banda, Shameem Buleya, Belinda Chihota, Joseph Chintedza, Carolyn Bolton, Thokozani Kalua, Roger Kouyos, Gilles Wandeler, Matthias Egger, Richard J. Lessells DTG Resistance in Patients with Previous ARV Experience and Viremia in Kenya Receiving DTG-Based ART Leonard Kingwara , Vera M Onwonga, Rukia S Madada, Peter Lokamar, John N Kiiru, James Wagude, Barbara Mambo, Caroline Mwangi, Rose Wafula, Kerri Penrose, Urvi M Parikh, Bhavna Chohan

677 1:40 PM

CROI 2024 61

New Investigator Scholarship

LB

NIS

Late-Breaking